Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18789649 | 0.87 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL18776643 | 0.81 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL14607672 | 0.71 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL18789638 | 0.69 | — | — | |
| SCHEMBL14962472 | 0.67 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL14573912 | 0.67 | — | — | |
| SCHEMBL9803653 | 0.65 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL1922429 | 0.64 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL17154258 | 0.61 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL18459312 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464930-B2 | Compositions and methods for treating estrogen-related medical disorders | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464930-B2 | Compositions and methods for treating estrogen-related medical disorders | HSD17B11, CYP19A1, ESR1 | ALDH1A1 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.